Abnormal N-6 Fatty Acid Metabolism in Cystic Fibrosis is Caused by Activation of AMP-activated Protein Kinase

Overview

Journal J Lipid Res

Publisher Elsevier

Specialty Biochemistry

Date 2014 May 27

PMID 24859760

Citations 14

Authors

Obi C Umunakwe

Adam C Seegmiller

Affiliations

Soon will be listed here.

Abstract

Cystic fibrosis (CF) patients and model systems exhibit consistent abnormalities in PUFA metabolism, including increased metabolism of linoleate to arachidonate. Recent studies have connected these abnormalities to increased expression and activity of the Δ6- and Δ5-desaturase enzymes. However, the mechanism connecting these changes to the CF transmembrane conductance regulator (CFTR) mutations responsible for CF is unknown. This study tests the hypothesis that increased activity of AMP-activated protein kinase (AMPK), previously described in CF bronchial epithelial cells, causes these changes in fatty acid metabolism by driving desaturase expression. Using CF bronchial epithelial cell culture models, we confirm elevated activity of AMPK in CF cells and show that it is due to increased phosphorylation of AMPK by Ca(2+)/calmodulin-dependent protein kinase kinase β (CaMKKβ). We also show that inhibition of AMPK or CaMKKβ reduces desaturase expression and reverses the metabolic alterations seen in CF cells. These results signify a novel AMPK-dependent mechanism linking the genetic defect in CF to alterations in PUFA metabolism.

Citing Articles

Fatty acid abnormalities in cystic fibrosis-the missing link for a cure?.

Drzymala-Czyz S, Walkowiak J, Colombo C, Alicandro G, Storrosten O, Kolsgaard M iScience. 2024; 27(11):111153.

PMID: 39620135 PMC: 11607544. DOI: 10.1016/j.isci.2024.111153.

Reduced Sphingosine in Cystic Fibrosis Increases Susceptibility to Infections.

Schnitker F, Liu Y, Keitsch S, Soddemann M, Verhasselt H, Kehrmann J Int J Mol Sci. 2023; 24(18).

PMID: 37762308 PMC: 10530875. DOI: 10.3390/ijms241814004.

Changes in Essential Fatty Acids and Ileal Genes Associated with Metabolizing Enzymes and Fatty Acid Transporters in Rodent Models of Cystic Fibrosis.

Shrestha N, Rout-Pitt N, McCarron A, Jackson C, Bulmer A, McAinch A Int J Mol Sci. 2023; 24(8).

PMID: 37108362 PMC: 10138779. DOI: 10.3390/ijms24087194.

The fatty acid imbalance of cystic fibrosis exists at birth independent of feeding in pig and ferret models.

Uc A, Strandvik B, Yao J, Liu X, Yi Y, Sun X Clin Sci (Lond). 2022; 136(24):1773-1791.

PMID: 36416119 PMC: 9747517. DOI: 10.1042/CS20220450.

Essential Fatty Acid Deficiency in Cystic Fibrosis Disease Progression: Role of Genotype and Sex.

Shrestha N, McCarron A, Rout-Pitt N, Donnelley M, Parsons D, Hryciw D Nutrients. 2022; 14(21).

PMID: 36364928 PMC: 9657825. DOI: 10.3390/nu14214666.

References

Ollero M, Astarita G, Guerrera I, Sermet-Gaudelus I, Trudel S, Piomelli D . Plasma lipidomics reveals potential prognostic signatures within a cohort of cystic fibrosis patients. J Lipid Res. 2011; 52(5):1011-22. PMC: 3073467. DOI: 10.1194/jlr.P013722. View

Bartling T, Drumm M . Oxidative stress causes IL8 promoter hyperacetylation in cystic fibrosis airway cell models. Am J Respir Cell Mol Biol. 2008; 40(1):58-65. PMC: 2606947. DOI: 10.1165/rcmb.2007-0464OC. View

Strandvik B . Fatty acid metabolism in cystic fibrosis. Prostaglandins Leukot Essent Fatty Acids. 2010; 83(3):121-9. DOI: 10.1016/j.plefa.2010.07.002. View

Corton J, Gillespie J, Hawley S, Hardie D . 5-aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells?. Eur J Biochem. 1995; 229(2):558-65. DOI: 10.1111/j.1432-1033.1995.tb20498.x. View

Van Biervliet S, Vanbillemont G, Van Biervliet J, Declercq D, Robberecht E, Christophe A . Relation between fatty acid composition and clinical status or genotype in cystic fibrosis patients. Ann Nutr Metab. 2008; 51(6):541-9. DOI: 10.1159/000114208. View

Katrangi W, Lawrenz J, Seegmiller A, Laposata M . Interactions of linoleic and alpha-linolenic acids in the development of fatty acid alterations in cystic fibrosis. Lipids. 2013; 48(4):333-42. DOI: 10.1007/s11745-013-3768-4. View

Njoroge S, Laposata M, Katrangi W, Seegmiller A . DHA and EPA reverse cystic fibrosis-related FA abnormalities by suppressing FA desaturase expression and activity. J Lipid Res. 2011; 53(2):257-65. PMC: 3269161. DOI: 10.1194/jlr.M018101. View

Woods A, Johnstone S, Dickerson K, Leiper F, Fryer L, Neumann D . LKB1 is the upstream kinase in the AMP-activated protein kinase cascade. Curr Biol. 2003; 13(22):2004-8. DOI: 10.1016/j.cub.2003.10.031. View

Tokumitsu H, Inuzuka H, Ishikawa Y, Ikeda M, Saji I, Kobayashi R . STO-609, a specific inhibitor of the Ca(2+)/calmodulin-dependent protein kinase kinase. J Biol Chem. 2002; 277(18):15813-8. DOI: 10.1074/jbc.M201075200. View

10.

Tabary O, Boncoeur E, de Martin R, Pepperkok R, Clement A, Schultz C . Calcium-dependent regulation of NF-(kappa)B activation in cystic fibrosis airway epithelial cells. Cell Signal. 2005; 18(5):652-60. DOI: 10.1016/j.cellsig.2005.06.004. View

11.

Carling D . The AMP-activated protein kinase cascade--a unifying system for energy control. Trends Biochem Sci. 2004; 29(1):18-24. DOI: 10.1016/j.tibs.2003.11.005. View

12.

Handa N, Takagi T, Saijo S, Kishishita S, Takaya D, Toyama M . Structural basis for compound C inhibition of the human AMP-activated protein kinase α2 subunit kinase domain. Acta Crystallogr D Biol Crystallogr. 2011; 67(Pt 5):480-7. DOI: 10.1107/S0907444911010201. View

13.

Batal I, Ericsoussi M, Cluette-Brown J, OSullivan B, Freedman S, Savaille J . Potential utility of plasma fatty acid analysis in the diagnosis of cystic fibrosis. Clin Chem. 2006; 53(1):78-84. DOI: 10.1373/clinchem.2006.077008. View

14.

Martins J, Kongsuphol P, Sammels E, Dahimene S, Aldehni F, Clarke L . F508del-CFTR increases intracellular Ca(2+) signaling that causes enhanced calcium-dependent Cl(-) conductance in cystic fibrosis. Biochim Biophys Acta. 2011; 1812(11):1385-92. DOI: 10.1016/j.bbadis.2011.08.008. View

15.

Antigny F, Norez C, Dannhoffer L, Bertrand J, Raveau D, Corbi P . Transient receptor potential canonical channel 6 links Ca2+ mishandling to cystic fibrosis transmembrane conductance regulator channel dysfunction in cystic fibrosis. Am J Respir Cell Mol Biol. 2010; 44(1):83-90. DOI: 10.1165/rcmb.2009-0347OC. View

16.

Bungard D, Fuerth B, Zeng P, Faubert B, Maas N, Viollet B . Signaling kinase AMPK activates stress-promoted transcription via histone H2B phosphorylation. Science. 2010; 329(5996):1201-5. PMC: 3922052. DOI: 10.1126/science.1191241. View

17.

Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J . Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest. 2001; 108(8):1167-74. PMC: 209533. DOI: 10.1172/JCI13505. View

18.

Ribeiro C, Paradiso A, Carew M, Shears S, Boucher R . Cystic fibrosis airway epithelial Ca2+ i signaling: the mechanism for the larger agonist-mediated Ca2+ i signals in human cystic fibrosis airway epithelia. J Biol Chem. 2005; 280(11):10202-9. DOI: 10.1074/jbc.M410617200. View

19.

Nakamura M, Nara T . Essential fatty acid synthesis and its regulation in mammals. Prostaglandins Leukot Essent Fatty Acids. 2003; 68(2):145-50. DOI: 10.1016/s0952-3278(02)00264-8. View

20.

Freedman S, Blanco P, Zaman M, Shea J, Ollero M, Hopper I . Association of cystic fibrosis with abnormalities in fatty acid metabolism. N Engl J Med. 2004; 350(6):560-9. DOI: 10.1056/NEJMoa021218. View